In what could be one of its last reports as a public company, Portland-based Covetrus Inc. (Nasdaq: CVET) said Thursday its second-quarter net sales rose 2% from the total during the same period last year.

The animal-health company also shrank its quarterly loss to $4 million, of 3 cents per share, for the three-month period that ended June 30, 2022. That’s down from a loss of $31 million, or 23 cents per share, during last year’s second quarter. Read more